Advisories
Reiteration of Generics Prescribing and Dispensing of Medicines
The DOH reiterates the importance of adhering to the “Generics Act of 1988” (RA No. 6675) during “Generics Awareness Month,” emphasizing proper prescribing and dispensing of generic medicines. For more information, click here.
Government-Mediated Access Price (GMAP) Adjustment of Selected Sanofi Drugs
The Department of Health has adjusted the retail price of selected Sanofi Drugs under the Government-Mediated Access Price (GMAP) program. To learn more about the changes, you can access the full details here.
Government-Mediated Access Price (GMAP) Adjustment of Telmisartan + Hydrochlorothiazide
The Department of Health has adjusted the retail price of Telmisartan + Hydrochlorothiazide under the Government-Mediated Access Price (GMAP) program. To learn more about the changes, you can access the full details here.
Government-Mediated Access Price (GMAP) Adjustment of Telmisartan
The Department of Health has adjusted the retail price of Telmisartan under the Government-Mediated Access Price (GMAP) program. To learn more about the changes, you can access the full details here.
Delisting of Etoposide Preparation in the Government Mediate Acces Price (GMAP) List
The Department of Health has decided to remove Etoposide Preparation under Government-Mediated Access Price (GMAP). To learn more about the changes, you can access the full contents here.
Advisory for the Request for Inputs and Recommendations on the Proposed Amendments to the Joint Administrative Order on the Implementing Guidelines of the Price Negotiation Board
Click the title to read more about the advisory.
Events
Citizen's Charter
Philippine Standard time
Contact Us:
Telephone Number: 02-86517800 Loc. 8104
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: pd@doh.gov.ph